Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Rebecca Panks

  • Home
  • Author: Rebecca Panks

The Italian acromegaly market will more than double in size by 2029, says GlobalData

Marketed therapeutics for the treatment of acromegaly generated sales of at least $33m in Italy in 2019. The value of this market is expected to more than double, surpassing $75m in 2029, according to GlobalData, a leading data and analytics company. GlobalData’s recently published report, ‘Acromegaly and Gigantism: Global Drug Forecast and Market Analysis to 2029’, reveals that the size of the Italian acromegaly market will increase at a 10-year compound annual growth rate (CAGR) of 8.6%. Magdalene Crabbe, Senior Pharmaceutical Analyst at GlobalData, comments: “The Italian market will experience rapid […]
Read more

European Telcos stop the lockdown freebies and focus on driving customers to digital services and channels, says GlobalData

The first round of COVID-19 lockdowns in Europe saw an immediate, high-profile and fairly universal response from European telcos announcing free consumer service benefits ranging from additional mobile data boosters to bonus family entertainment content. However, the second wave has, so far, seen very little such activity – with telcos instead encouraging customers to self-service […]
Read more

Avastin and Tecentriq combination to take over standard of care in hepatocellular carcinoma, says GlobalData

Following the string of approvals this year for Roche’s combination of Avastin (bevacizumab) and Tecentriq (atezolizumab), key opinion leaders interviewed by GlobalData from the five major European pharmaceutical markets (5EU*) and China have noted that the majority of patients would receive Avastin plus Tecentriq in the first-line setting. This offers a major competition to current […]
Read more
,

Smarter hearables to overcome COVID-19 slowdowns on path towards becoming $146bn industry, says GlobalData

While lockdowns in China in early 2020 damaged the number of shipments of hearables technology and delayed production, adoption of this technology by consumers has remained strong. This was driven by increased digital media consumption, the widespread shift to home-working and the popularity of virtual fitness coaching. As hearables manufacturers continue to add more artificial intelligence […]
Read more

While Pfizer and BioNTech’s ‘90% efficacy’ data raises expectations for mRNA vaccines, it will take many more months for key questions to be answered, says GlobalData

Following the news that Pfizer and BioNTech have announced their COVID-19 vaccine is more than 90% effective in first interim data readout; Philipp Rosenbaum, PhD, Senior Infectious Diseases Analyst at GlobalData, a leading data and analytics company, offers his view: “Experts initially assumed that first iterations of a COVID-19 vaccine would show efficacies not much […]
Read more

With US election days away, speed of future COVID-19 therapies and vaccine hang in the balance, says GlobalData

The use of Emergency Use Authorizations (EUA) has been deeply polarizing in the US. With only days left until the presidential election, a growing number of pharmaceutical companies are expected to file for emergency use of their products—both therapeutic and prophylactic—to allow for expedited approval and distribution, according to GlobalData, a leading data and analytics […]
Read more

PAH market forecast to grow at 5% CAGR by 2029, says GlobalData

With recent pipeline approvals of varying mechanisms and an influx of newly diagnosed patients, the pulmonary arterial hypertension (PAH) market is expected to grow at a 5% compound annual growth rate (CAGR) from 2019 to 2029 in the seven major markets*, says GlobalData, a leading data and analytics company. Kajal Jaddoo, Associate Pharma Analyst at […]
Read more

Shared mobility faces major COVID-19 threat, says GlobalData

A new study by GlobalData, a leading data and analytics company, highlights the threat to the formerly buoyant ride-hail sector posed by changed consumer attitudes across the world due to the COVID-19 pandemic. Mike Vousden, Automotive Analyst at GlobalData comments: “In simple terms, the concept of shared mobility is now in question as consumers re-evaluate […]
Read more

Gibbs&Cox’s latest DARPA contracts yet another leap forward in USV industry, says GlobalData

Following the recent news that Defense Advanced Research Projects Agency (DARPA) has awarded seven contracts for the first phase of the No Manning Required Ship (NOMARS) program; Captain (Rtrd) Nurettin Sevi, Aerospace and Defense Analyst at GlobalData, a leading data and analytics company, offers his view on the situation: “The US Department of Defense (DoD) has been making […]
Read more

Skadden and Kirkland & Ellis were top legal advisers by value and volume for Q1-Q3 2020, says GlobalData

Skadden, Arps, Slate, Meagher & Flom and Kirkland & Ellis were the top mergers and acquisitions (M&A) legal advisers for Q1-Q3 2020 by value and volume, respectively, according to GlobalData’s Financial Deals Database. Skadden advised on 130 deals worth US$202.1bn, which was the highest among all the advisers. Meanwhile, Kirkland & Ellis led in volume terms and […]
Read more

Impact of COVID-19 forces pipeline operators in the US to continue adopting conservative strategies, says GlobalData

The COVID-19 pandemic has significantly impacted the US pipeline sector and operators are left with little choice than to adopt strategies to save cash. As a result, several pipeline companies in the country continue to delay or stall pipeline projects or reduce capital expenditure. In hindsight, pipeline operators are also analyzing the impact of COVID-19 […]
Read more
1 … 33 34 35 36 37 … 77